NCT05233995

Brief Summary

Phase III clinical trial to evaluate the efficacy of the open abdomen as bridging therapy to perform transit reconstruction in patients with anastomotic dehiscence. It is a randomized controlled single-center study that will be carried out at the Virgen del Rocío University Hospital in Seville.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Aug 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 19, 2021

Completed
3 months until next milestone

First Posted

Study publicly available on registry

February 10, 2022

Completed
6 months until next milestone

Study Start

First participant enrolled

August 1, 2022

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2024

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2024

Completed
Last Updated

June 15, 2022

Status Verified

June 1, 2022

Enrollment Period

1.8 years

First QC Date

November 19, 2021

Last Update Submit

June 11, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Efficacy-Stoma after discharge

    To assess the efficacy of the open abdomen surgical strategy with delayed anastomosis in patients requiring reoperation for anastomotic dehiscence. Number of stoma after discharge

    up to 57 months

Secondary Outcomes (5)

  • Mortality

    up to 57 months

  • Intensive Care Unit stay

    up to 57 months

  • Complications of open abdomen

    up to 57 months

  • Early complications

    up to 57 months

  • Late complications

    up to 57 months

Study Arms (2)

Intervention group

EXPERIMENTAL

The patients included in the experimental group will be operated on, performing the resection of the intestinal segment affected by the dehiscence, the sectioned intestinal ends will be left without anastomosis, and open abdomen therapy will be established. After surgery, the patient will be cared for in the intensive care unit where intensive resuscitation will be carried out in order to improve the general conditions of the patient. After 48 ± 24 hours, a second surgical procedure will be performed where local conditions will be evaluated and the possibility of performing a delayed anastomosis will be evaluated.

Procedure: Damage Control Surgery

Control group

ACTIVE COMPARATOR

The patients included in the control group will be operated on with a resection of the affected intestinal segment and a stoma with or without associated mucosal fistula will be performed at the same surgical time. After the procedure, the patient will be cared for in the intensive care unit in order to improve the general conditions of the patient.

Procedure: Damage Control Surgery

Interventions

Delayed anastomosis

Control groupIntervention group

Eligibility Criteria

Age14 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with intestinal, ileocolic, colo-colic and colorectal anastomosis dehiscence.

You may not qualify if:

  • Dehiscence of colorectal anastomosis in the middle or lower rectum.
  • Dehiscence of esophagus-gastric or gastro-intestinal anastomosis.
  • Dehiscence of a colorectal anastomosis in which it is impossible to close the rectal stump.
  • Failure to sign the informed consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital Universitario Virgen del Rocío, Sevilla

Seville, 41013, Spain

RECRUITING

Study Officials

  • Virginia Durán Muñoz-Cruzado, PhD

    Fundación Pública Andaluza para la gestión de la Investigación en Sevilla

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Virginia Durán Muñoz-Cruzado, PhD

CONTACT

Servicio de Cirugía General y del Aparato Digestivo Hospital Universitario Virgen del Rocío

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 19, 2021

First Posted

February 10, 2022

Study Start

August 1, 2022

Primary Completion

May 1, 2024

Study Completion

September 1, 2024

Last Updated

June 15, 2022

Record last verified: 2022-06

Locations